For a company to be eligible for SME R&D incentives, it must file its accounts as a Going Concern.

This guidance note summarises the Going Concern principle, the responsibilities of both Management and Auditors in assessing its applicability and how the process evolves for both audited and unaudited Life Sciences companies.

This content is restricted to members. To view this content please register or login below to view this content.

Register to receive up-to-date information and advice on tax developments within your industry.